Quick Summary
Safflower (Carthamus tinctorius) is a traditional botanical medicine used for various health conditions, including cardiovascular diseases, fibrotic and inflammatory disorders, and some neurological conditions. Clinical studies and meta-analyses often examine safflower as part of compound formulations or injectable mixtures (e.g., Xuebijing), commonly combined with conventional Western medicine. Current human clinical evidence supports its potential role in adjunctive therapies, particularly for cardiovascular conditions, inflammatory diseases, and certain complications of diabetes. Mechanistic and preclinical studies indicate anti-inflammatory, antioxidant, and immunomodulatory effects, linked to modulation of inflammatory cytokines and vascular function. However, safflower is mainly studied as part of multi-herb formulations rather than a single-herb intervention in clinical trials, and the overall evidence base has methodological limitations.
What is It?
Safflower (Carthamus tinctorius) is a herbaceous plant traditionally used in botanical medicine. The seeds and flowers are commonly utilized, often incorporated into patent herbal injections and combination therapies, mainly within the framework of Traditional Chinese Medicine (TCM). It is not commonly used as a stand-alone herbal remedy in clinical settings.
Traditional Uses
- Cardiovascular health support, including angina and atherosclerosis
- Reducing inflammation and modulating immune responses
- Management of fibrotic conditions such as systemic sclerosis (based on animal studies)
- Neurological and cognitive symptom relief, especially post-stroke rehabilitation
- Addressing metabolic and cardiovascular complications related to diabetes
Active Compounds
The specific active compounds responsible for safflower’s biological activity are not fully delineated in clinical research; however, mechanistic studies indicate the involvement of bioactive constituents with potential anti-inflammatory, antioxidant, and immunomodulatory properties. These may contribute to modulation of cytokines and vascular function.
Potential Benefits with Evidence Levels
- Cardiovascular Health (Moderate evidence): Clinical trials of Chinese patent formulations containing safflower, such as Xuebijing and Danhong injections, show improved outcomes in cardiovascular diseases like unstable angina, hypertensive intracerebral hemorrhage, and atherosclerosis when combined with standard therapy. Reported benefits include reductions in inflammatory markers (hs-CRP, TNF-α, IL-6), improved cardiac function, and symptom relief. Evidence mostly comes from randomized controlled trials of multi-herb combinations.
- Inflammation and Immune Modulation (Preliminary to moderate evidence): Safflower-containing formulations demonstrated reductions in systemic inflammation biomarkers in conditions such as sepsis and acute pancreatitis. Preclinical research supports anti-inflammatory and antioxidant effects. Evidence mainly derives from combination herbal products rather than isolated safflower.
- Fibrotic Diseases (Systemic Sclerosis) (Preclinical animal studies): An aqueous safflower extract reduced fibrosis and inflammation in a bleomycin-induced mouse model of systemic sclerosis, potentially through effects on gut microbiota and metabolism. Human clinical data are lacking.
- Neurological and Cognitive Disorders (Preliminary clinical and preclinical evidence): Safflower is part of multi-herb formulations traditionally used for neurological symptoms such as sequelae of cerebral infarction and stroke rehabilitation. Direct evidence on safflower alone is limited. Preclinical studies suggest neuroprotective and anti-inflammatory mechanisms.
- Diabetes-Related Cardiovascular and Metabolic Complications (Limited clinical evidence): Some small to moderate clinical trials indicate that safflower-containing formulations may reduce cardiovascular inflammation and improve lipid profiles in type 2 diabetes patients with ischemic disease. These studies are mainly from integrated TCM and Western medicine approaches.
Side Effects
Safflower-containing products are generally well tolerated when used under medical supervision, particularly as part of multi-herb injections. Mild adverse effects occasionally reported include skin irritation such as erythema and pruritus, especially with topical application of herbal combinations. No serious adverse drug events have been observed in meta-analyses of safflower-containing injections.
Drug Interactions
Specific data on drug interactions with safflower alone are scarce. However, cautious use is advised when combined with Western medications, particularly anticoagulants and antiplatelet agents, due to safflower’s potential effects on blood circulation. Further research is needed to clarify herb-drug interaction profiles in integrated medicine settings.
Who Should Avoid It
No explicit contraindications for safflower have been identified in the current literature. Use in combination with standard medical therapies should be overseen by healthcare professionals. Individuals should consider their personal tolerance, medical history, and existing conditions before use. Due to lack of data, pregnant or breastfeeding women should avoid safflower or use it only under medical advice.
Evidence Limitations
- Most clinical evidence pertains to safflower as part of multi-herb formulations or patent injections, making it difficult to attribute effects solely to safflower.
- Methodological issues such as small sample sizes, lack of placebo controls, and variable trial quality limit confidence in findings.
- Preclinical studies predominate in elucidating mechanisms, with limited direct clinical evaluation of pure safflower preparations.
- Safety data for long-term use, and for specific populations including pregnant and breastfeeding women, are insufficient.
- Heterogeneity in study design and outcome measures precludes definitive conclusions about efficacy and safety.
References
- Lin R, Yu Y, Yin Y, et al. (2025). Chinese herbal foot baths as a new strategy for diabetic foot with Wagner grade of 0 or 1: a meta-analysis and data mining. Europe PMC.
- Zong L, Zhou D, Zeng Y, et al. (2025). Efficacy and safety of combined Chinese and Western medicine therapy for hypertensive intracerebral hemorrhage: A systematic review and meta-analysis of randomized controlled trials. Europe PMC.
- Kan Z, Yan W, Chen C, et al. (2025). Efficacy and safety of Danhong injection on inflammatory factors and vascular endothelial function in patients with unstable angina pectoris: a systematic review and meta-analysis of randomized clinical trials. Europe PMC.
- Shu B, Zhou X, Fan J, et al. (2025). Comparative efficacy and safety of Xuebijing injection as adjuvant therapy in sepsis-associated acute kidney injury: a systematic review and meta-analysis. Europe PMC.
- Zhang Y, Ping X, Wang C, et al. (2026). Exploring the anti-fibrotic effects of safflower in systemic sclerosis based on metabolomics and gut microbiota analyses. Europe PMC.
- Yun S, Oh J, Chu H, et al. (2024). Systematic Review of Preclinical Studies on the Efficacy and Mechanisms of Herbal Medicines in Post-Myocardial Infarction Heart Failure with Reduced Ejection Fraction. Europe PMC.
- Tang J, Song T, Kuang M, Liu H. (2024). Analysis of online prescription patterns in Chinese patients with sequelae of cerebral infarction: a real-world study. Europe PMC.
- Safflower (Carthamus tinctorius) Seed. (2020). Springer Singapore.
Last Reviewed
June 2024
Informational Disclaimer: This page is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new treatment or herbal supplement, especially if you have underlying health conditions or are taking other medications.